RAVER1
Ribonucleoprotein PTB-binding 1
Also known as: RAVR1_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- Q8IY67
- Gene
- RAVER1
- Canonical length
- 606 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
No narrative summary is available for RAVER1 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
606 residues, UniProt reviewed canonical sequence.
>Q8IY67|RAVER1
1 MAADVSVTHR PPLSPKSGAE VEAGDAAERR APEEELPPLD PEEIRKRLEH TERQFRNRRK
61 ILIRGLPGDV TNQEVHDLLS DYELKYCFVD KYKGTAFVTL LNGEQAEAAI NAFHQSRLRE
121 RELSVQLQPT DALLCVANLP PSLTQQQFEE LVRPFGSLER CFLVYSERTG QSKGYGFAEY
181 MKKDSAARAK SDLLGKPLGP RTLYVHWTDA GQLTPALLHS RCLCVDRLPP GFNDVDALCR
241 ALSAVHSPTF CQLACGQDGQ LKGFAVLEYE TAEMAEEAQQ QADGLSLGGS HLRVSFCAPG
301 PPGRSMLAAL IAAQATALNR GKGLLPEPNI LQLLNNLGPS ASLQLLLNPL LHGSAGGKQG
361 LLGAPPAMPL LNGPALSTAL LQLALQTQGQ KKPGILGDSP LGALQPGAQP ANPLLGELPA
421 GGGLPPELPP RRGKPPPLLP SVLGPAGGDR EALGLGPPAA QLTPPPAPVG LRGSGLRGPL
481 SHFYSGSPTS YFTSGLQAGL KQSHLSKAIG SSPLGSGEGL LGLSPGPNGH SHLLKVRAGG
541 GDMQGWEAPA PQRPLTRPAL PSVSRPHWAA RNAALPTCCP RPSPAQKAAM WASTPRASAA
601 TTRTPTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RAVER1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- endometrium: 21 nTPM
- small intestine: 21 nTPM
- spleen: 20 nTPM
- colon: 18 nTPM
- ovary: 18 nTPM
- bone marrow: 17 nTPM
Single-cell type
- pdcs: 15 nCPM
- ependymal cells: 14 nCPM
- choroid plexus epithelial cells: 14 nCPM
- rod photoreceptor cells: 13 nCPM
- myonuclei: 12 nCPM
- adrenal medulla cells: 11 nCPM
Immune cell
- memory CD8 T-cell: 4.6 nTPM
- non-classical monocyte: 3.3 nTPM
- gdT-cell: 3.2 nTPM
- memory CD4 T-cell: 2.7 nTPM
- myeloid DC: 2.1 nTPM
- total PBMC: 2.1 nTPM
Brain region
- medulla oblongata: 26 nTPM
- choroid plexus: 23 nTPM
- midbrain: 21 nTPM
- thalamus: 21 nTPM
- basal ganglia: 20 nTPM
- pons: 20 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.36
- gnomAD pLI
- 0.91
- gnomAD missense Z
- 1.46
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RNA recognition motif domain
- Nucleotide-binding alpha-beta plait domain superfamily
- RNA-binding domain superfamily
- Eukaryotic RNA-binding
- RNA recognition motif
- Ribonucleoprotein PTB-binding 1, RNA recognition motif 1
- Ribonucleoprotein PTB-binding 1, RNA recognition motif 3
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RAVER1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RAVER1 as an antibody target. Whether an autoantibody or antibody against RAVER1 could matter depends on whether native RAVER1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RAVER1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RAVER1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...